Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Research suggests potential treatment target to slow lymphoma tumor growth

Research suggests potential treatment target to slow lymphoma tumor growth

Horizon Discovery expands cell-based CRISPR screening services

Horizon Discovery expands cell-based CRISPR screening services

Majority of patients with mantle cell lymphoma may benefit from CAR T-cell therapy KTE-X19

Majority of patients with mantle cell lymphoma may benefit from CAR T-cell therapy KTE-X19

New blood test detects more than 50 types of cancer, including at early, more treatable stages

New blood test detects more than 50 types of cancer, including at early, more treatable stages

Her genetic test revealed a microscopic problem — and a jumbo price tag

Her genetic test revealed a microscopic problem — and a jumbo price tag

New blood test accurately detects more than 50 types of cancer

New blood test accurately detects more than 50 types of cancer

3D chromatin landscapes in T cell acute lymphoblastic leukemia important beyond DNA code changes

3D chromatin landscapes in T cell acute lymphoblastic leukemia important beyond DNA code changes

Changes in 3D genetic structure equally important as DNA code mutations in childhood leukemia

Changes in 3D genetic structure equally important as DNA code mutations in childhood leukemia

Revolutionary technology could help identify more effective cancer drug combinations

Revolutionary technology could help identify more effective cancer drug combinations

People with a cancer history have increased risk of developing atrial fibrillation

People with a cancer history have increased risk of developing atrial fibrillation

Immunotherapy combination can shrink viral reservoir in HIV model

Immunotherapy combination can shrink viral reservoir in HIV model

Immunosuppressive therapy does not increase risk of vulvar or vaginal cancer in women with IBD

Immunosuppressive therapy does not increase risk of vulvar or vaginal cancer in women with IBD

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Investigational CAR-T therapy for Hodgkin lymphoma receives fast-track designation from FDA

Study: Five-year survival rate for adolescents and young adults with cancer has improved

Study: Five-year survival rate for adolescents and young adults with cancer has improved

Maine voters consider U-turn on vaccine exemptions

Maine voters consider U-turn on vaccine exemptions

Study finds improvements in survival rates for all cancers in young adults

Study finds improvements in survival rates for all cancers in young adults

DNA topological problems may cause lymphoma, study shows

DNA topological problems may cause lymphoma, study shows

Researchers reveal new vulnerability in MYC-driven lymphomas

Researchers reveal new vulnerability in MYC-driven lymphomas

Bioengineers create light-controllable CAR T cells for cancer immunotherapy

Bioengineers create light-controllable CAR T cells for cancer immunotherapy

Cancer risk in psoriatic patients

Cancer risk in psoriatic patients